PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is a top small cap stock with high growth potential. Truist lowered its price target to $50 from $64 but maintained a Buy rating, expecting healthy Q3 results in the MedTech sector amidst potential stock volatility.